Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
9/17/2025
J&J, Roche Said to Be in Talks with Henlius over PD-L1 ADC HLX43
9/17/2025
Two Chinese Biotechs File for IPOs in Hong Kong as Losses Mount but Pi...
9/15/2025
Chinese Biotech Startups Face Mixed Earnings amid Ambitious Global Exp...
9/15/2025
FibroGen Settles SEC Allegations Over Roxadustat Data Manipulation
9/15/2025
BMS to Divest Majority Stake in Historic China JV to Hillhouse Capital
9/15/2025
GenFleet Therapeutics Launches Hong Kong IPO to Raise Up to HK$1.58 B
9/15/2025
Rui Thera Secures Over ¥200M in Series A Funding
9/13/2025
Bayer Expands China Presence with New Innovation Platform and Biotech ...
9/13/2025
Nanjing's Triastek Builds World's Largest 3D-Printed Pharma Plant
9/11/2025
RabPharma Raises Oversubscribed Series A++ to Push Ahead with RAB001d ...
9/11/2025
HKU-Med, GBAICTI and GSK Join Forces to Boost Real-World Clinical Rese...
9/11/2025
Chinese Biotechs Face Rising Hurdles in Advanced Therapies
9/10/2025
Trump Admin Weighs Tighter Curbs on U.S. Licensing of China-Originated...
9/10/2025
YolTech Secures $45M to Accelerate CRISPR Therapy Development Amid U.S...
9/8/2025
Epigenic Secures $60M in Series B Financing to Advance Epigenetic Drug...
9/5/2025
Hengrui Licenses Myosin Inhibitor HRS-1893 to U.S. Startup Braveheart ...
9/4/2025
iRegene Raises Series B+ to Advance Parkinson's and Ophthalmology Cell...
9/3/2025
E-nitiate Biopharma Secures ~¥200M in Series B Funding to Advance Au...
9/3/2025
Sanofi China Receives Approval for Tzield to Delay Progression of Type...
9/3/2025
Argo Biopharma Strikes $5.2B Cardiovascular Collaboration with Novarti...
9/3/2025
China Biopharma Sees $320M Upfronts and $8.5B Milestones in H1 2025 Li...
9/3/2025
Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...
9/2/2025
Astellas Accelerates Growth and Innovation in China
9/2/2025
Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...
9/1/2025
Fosun Licenses Accro's TYK2/JAK1 Inhibitor AC-201 in Greater China
9/1/2025
Ennovabio Secures New Financing to Advance Pipeline for Immune and Met...
9/1/2025
Convalife's HKEX IPO Application Gets Green Light
8/29/2025
Eli Lilly Partners with JD Health for Popular Weight-Loss Medicines
8/29/2025
Fosun Secures Exclusive Rights to ACCRO's AC-201 in Greater China
8/29/2025
Adcoris Raises CNY Tens of Millions to Advance Next-Gen ADC Programs
Page:
1
/
25
Total number of articles:
741
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit